Anne Marie Cook

This profile gathers the share dealings of Anne Marie Cook across 2 companies, led by Sage Therapeutics, Inc. and Phathom Pharmaceuticals, Inc. Over a trading history stretching from 15 June 2021 to 10 February 2026, the count stands at 9 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 12 February 2026: a share grant, in Phathom Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.